Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hydrazones | 1 | 2024 | 42 | 0.920 |
Why?
|
| Cardiotonic Agents | 1 | 2024 | 156 | 0.850 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 256 | 0.800 |
Why?
|
| Pyridazines | 1 | 2024 | 324 | 0.740 |
Why?
|
| Myocardium | 1 | 2024 | 1232 | 0.630 |
Why?
|
| Fibroblasts | 2 | 2024 | 1654 | 0.620 |
Why?
|
| Oxidative Stress | 1 | 2024 | 1149 | 0.590 |
Why?
|
| Immunoglobulin E | 7 | 2003 | 182 | 0.510 |
Why?
|
| Allergens | 7 | 2003 | 252 | 0.460 |
Why?
|
| Plant Proteins | 5 | 2003 | 133 | 0.310 |
Why?
|
| Signal Transduction | 2 | 2024 | 12103 | 0.270 |
Why?
|
| Hypersensitivity | 3 | 2003 | 220 | 0.250 |
Why?
|
| Heart Failure, Diastolic | 1 | 2024 | 10 | 0.240 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 57 | 0.230 |
Why?
|
| Diastole | 1 | 2024 | 187 | 0.230 |
Why?
|
| Skin Tests | 3 | 2003 | 101 | 0.230 |
Why?
|
| Fibrosis | 1 | 2024 | 733 | 0.190 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2024 | 400 | 0.180 |
Why?
|
| Transcriptional Activation | 1 | 2024 | 1111 | 0.180 |
Why?
|
| Antigens, Dermatophagoides | 3 | 2003 | 11 | 0.160 |
Why?
|
| Receptors, Progesterone | 2 | 2005 | 1604 | 0.160 |
Why?
|
| Cell Survival | 1 | 2024 | 3063 | 0.150 |
Why?
|
| Antigen-Antibody Reactions | 2 | 2002 | 89 | 0.130 |
Why?
|
| Rats | 1 | 2024 | 6441 | 0.120 |
Why?
|
| Antigens, Plant | 5 | 2003 | 34 | 0.120 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2004 | 131 | 0.120 |
Why?
|
| Immunoglobulin Isotypes | 2 | 2002 | 34 | 0.110 |
Why?
|
| Serine | 1 | 2004 | 391 | 0.110 |
Why?
|
| Immunoglobulin G | 3 | 2002 | 1129 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2005 | 885 | 0.090 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 550 | 0.090 |
Why?
|
| Glycoproteins | 2 | 2002 | 779 | 0.090 |
Why?
|
| Apoptosis | 1 | 2024 | 7757 | 0.090 |
Why?
|
| Transcription, Genetic | 2 | 2005 | 3339 | 0.090 |
Why?
|
| Hypersensitivity, Immediate | 1 | 1999 | 24 | 0.080 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1999 | 244 | 0.080 |
Why?
|
| Asthma | 2 | 2003 | 895 | 0.080 |
Why?
|
| Antibody Affinity | 3 | 2002 | 61 | 0.070 |
Why?
|
| Antibody Specificity | 3 | 2002 | 336 | 0.060 |
Why?
|
| Mice | 2 | 2024 | 35600 | 0.060 |
Why?
|
| Progestins | 2 | 2005 | 92 | 0.060 |
Why?
|
| Animals | 3 | 2024 | 61956 | 0.050 |
Why?
|
| Binding, Competitive | 2 | 2002 | 329 | 0.050 |
Why?
|
| Asteraceae | 2 | 2000 | 2 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2003 | 3949 | 0.040 |
Why?
|
| Pollen | 2 | 2000 | 46 | 0.040 |
Why?
|
| Immunotherapy | 2 | 2000 | 3557 | 0.040 |
Why?
|
| Humans | 10 | 2024 | 270740 | 0.040 |
Why?
|
| Mitogens | 1 | 2004 | 80 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 274 | 0.030 |
Why?
|
| Mites | 1 | 2003 | 6 | 0.030 |
Why?
|
| Arthropod Proteins | 1 | 2003 | 11 | 0.030 |
Why?
|
| Ambrosia | 1 | 2003 | 14 | 0.030 |
Why?
|
| Alanine | 1 | 2004 | 247 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2004 | 299 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 295 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2005 | 589 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2005 | 16215 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2005 | 895 | 0.030 |
Why?
|
| Patch Tests | 1 | 2003 | 7 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2004 | 252 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2003 | 170 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2004 | 657 | 0.030 |
Why?
|
| Cyclin D1 | 1 | 2005 | 589 | 0.030 |
Why?
|
| Dermatitis, Atopic | 1 | 2003 | 41 | 0.030 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 262 | 0.030 |
Why?
|
| Cyclin E | 1 | 2004 | 283 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2003 | 327 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2004 | 848 | 0.030 |
Why?
|
| Differential Threshold | 1 | 2002 | 14 | 0.030 |
Why?
|
| Ligands | 1 | 2004 | 1012 | 0.030 |
Why?
|
| Binding Sites, Antibody | 1 | 2002 | 127 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 202 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2003 | 497 | 0.020 |
Why?
|
| Adolescent | 4 | 2003 | 32767 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 746 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2004 | 1685 | 0.020 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2002 | 174 | 0.020 |
Why?
|
| Age Distribution | 1 | 2003 | 727 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2004 | 1810 | 0.020 |
Why?
|
| Child | 4 | 2003 | 30559 | 0.020 |
Why?
|
| RNA Interference | 1 | 2004 | 1388 | 0.020 |
Why?
|
| Immunodominant Epitopes | 1 | 2000 | 63 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2004 | 1474 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2005 | 1712 | 0.020 |
Why?
|
| Cell Line, Tumor | 2 | 2005 | 14849 | 0.020 |
Why?
|
| Genes, Immunoglobulin | 1 | 1999 | 86 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2004 | 2090 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2005 | 2137 | 0.020 |
Why?
|
| Rhinitis | 1 | 1999 | 41 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2004 | 3584 | 0.020 |
Why?
|
| Family | 1 | 2003 | 783 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1999 | 263 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2005 | 3045 | 0.020 |
Why?
|
| Adult | 5 | 2003 | 82040 | 0.020 |
Why?
|
| Immunoassay | 1 | 1999 | 214 | 0.020 |
Why?
|
| Cell Line | 1 | 2005 | 5338 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 1903 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2004 | 4942 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2004 | 5694 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 3194 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 2115 | 0.020 |
Why?
|
| Middle Aged | 4 | 2003 | 90352 | 0.020 |
Why?
|
| Male | 5 | 2003 | 128315 | 0.020 |
Why?
|
| Age Factors | 1 | 2003 | 5457 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2000 | 4567 | 0.010 |
Why?
|
| Female | 5 | 2003 | 148940 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2003 | 30998 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2000 | 6685 | 0.010 |
Why?
|
| Incidence | 1 | 2003 | 5824 | 0.010 |
Why?
|
| Aged | 3 | 2003 | 73333 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2005 | 7238 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2003 | 4372 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2003 | 6764 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2003 | 9470 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1999 | 4130 | 0.010 |
Why?
|